Clinical trialNCT00362193CompletedPhase 4Interventional

Glycemic Relapse Prevention: Maintenance Dose Assessment

SponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Enrollment165Type 2 Diabetes

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This purpose of this study is to determine the optimal frequency of maintenance intervention needed to prevent glycemic relapse.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Tom A Elasy, MD, MPH
Vanderbilt University
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Jun 2002
Primary completion: —
Completion: 28 Feb 2007
Last update posted: 15 Feb 2010
Registered enrollment: 165
Registry id: NCT00362193

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.